342 related articles for article (PubMed ID: 20424515)
1. β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
Zhang D; Ma QY; Hu HT; Zhang M
Cancer Biol Ther; 2010 Jul; 10(1):19-29. PubMed ID: 20424515
[TBL] [Abstract][Full Text] [Related]
2. β2-adrenoceptor blockage induces G1/S phase arrest and apoptosis in pancreatic cancer cells via Ras/Akt/NFκB pathway.
Zhang D; Ma Q; Wang Z; Zhang M; Guo K; Wang F; Wu E
Mol Cancer; 2011 Nov; 10():146. PubMed ID: 22118662
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine-induced invasion by pancreatic cancer cells is inhibited by propranolol.
Guo K; Ma Q; Wang L; Hu H; Li J; Zhang D; Zhang M
Oncol Rep; 2009 Oct; 22(4):825-30. PubMed ID: 19724861
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of pancreatic cancer cell proliferation by propranolol occurs through apoptosis induction: the study of beta-adrenoceptor antagonist's anticancer effect in pancreatic cancer cell.
Zhang D; Ma Q; Shen S; Hu H
Pancreas; 2009 Jan; 38(1):94-100. PubMed ID: 19106745
[TBL] [Abstract][Full Text] [Related]
5. Beta-adrenoceptor action on pancreatic cancer cell proliferation and tumor growth in mice.
Lin X; Luo K; Lv Z; Huang J
Hepatogastroenterology; 2012; 59(114):584-8. PubMed ID: 22353526
[TBL] [Abstract][Full Text] [Related]
6. Chronic stress promotes gastric cancer progression and metastasis: an essential role for ADRB2.
Zhang X; Zhang Y; He Z; Yin K; Li B; Zhang L; Xu Z
Cell Death Dis; 2019 Oct; 10(11):788. PubMed ID: 31624248
[TBL] [Abstract][Full Text] [Related]
7. Nafamostat mesilate can prevent adhesion, invasion and peritoneal dissemination of pancreatic cancer thorough nuclear factor kappa-B inhibition.
Fujiwara Y; Furukawa K; Haruki K; Shimada Y; Iida T; Shiba H; Uwagawa T; Ohashi T; Yanaga K
J Hepatobiliary Pancreat Sci; 2011 Sep; 18(5):731-9. PubMed ID: 21484229
[TBL] [Abstract][Full Text] [Related]
8. Beta-adrenergic growth regulation of human cancer cell lines derived from pancreatic ductal carcinomas.
Weddle DL; Tithoff P; Williams M; Schuller HM
Carcinogenesis; 2001 Mar; 22(3):473-9. PubMed ID: 11238189
[TBL] [Abstract][Full Text] [Related]
9. Norepinephrine stimulates pancreatic cancer cell proliferation, migration and invasion via β-adrenergic receptor-dependent activation of P38/MAPK pathway.
Huang XY; Wang HC; Yuan Z; Huang J; Zheng Q
Hepatogastroenterology; 2012 May; 59(115):889-93. PubMed ID: 22020907
[TBL] [Abstract][Full Text] [Related]
10. Down-regulation of platelet-derived growth factor-D inhibits cell growth and angiogenesis through inactivation of Notch-1 and nuclear factor-kappaB signaling.
Wang Z; Kong D; Banerjee S; Li Y; Adsay NV; Abbruzzese J; Sarkar FH
Cancer Res; 2007 Dec; 67(23):11377-85. PubMed ID: 18056465
[TBL] [Abstract][Full Text] [Related]
11. β2-adrenoceptor blocker synergizes with gemcitabine to inhibit the proliferation of pancreatic cancer cells via apoptosis induction.
Shan T; Ma Q; Zhang D; Guo K; Liu H; Wang F; Wu E
Eur J Pharmacol; 2011 Aug; 665(1-3):1-7. PubMed ID: 21570961
[TBL] [Abstract][Full Text] [Related]
12. Anti-Neuroinflammatory Effects of Fucoxanthin via Inhibition of Akt/NF-κB and MAPKs/AP-1 Pathways and Activation of PKA/CREB Pathway in Lipopolysaccharide-Activated BV-2 Microglial Cells.
Zhao D; Kwon SH; Chun YS; Gu MY; Yang HO
Neurochem Res; 2017 Feb; 42(2):667-677. PubMed ID: 27933547
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
Wang Z; Sengupta R; Banerjee S; Li Y; Zhang Y; Rahman KM; Aboukameel A; Mohammad R; Majumdar AP; Abbruzzese JL; Sarkar FH
Cancer Res; 2006 Aug; 66(15):7653-60. PubMed ID: 16885366
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-32 expression in the pancreas.
Nishida A; Andoh A; Inatomi O; Fujiyama Y
J Biol Chem; 2009 Jun; 284(26):17868-76. PubMed ID: 19386602
[TBL] [Abstract][Full Text] [Related]
15. Quercetin-3-O-glucuronide inhibits noradrenaline-promoted invasion of MDA-MB-231 human breast cancer cells by blocking β₂-adrenergic signaling.
Yamazaki S; Miyoshi N; Kawabata K; Yasuda M; Shimoi K
Arch Biochem Biophys; 2014 Sep; 557():18-27. PubMed ID: 24929186
[TBL] [Abstract][Full Text] [Related]
16. Quercetin inhibits migration and invasion of SAS human oral cancer cells through inhibition of NF-κB and matrix metalloproteinase-2/-9 signaling pathways.
Lai WW; Hsu SC; Chueh FS; Chen YY; Yang JS; Lin JP; Lien JC; Tsai CH; Chung JG
Anticancer Res; 2013 May; 33(5):1941-50. PubMed ID: 23645742
[TBL] [Abstract][Full Text] [Related]
17. β-Adrenergic system, a backstage manipulator regulating tumour progression and drug target in cancer therapy.
Tang J; Li Z; Lu L; Cho CH
Semin Cancer Biol; 2013 Dec; 23(6 Pt B):533-42. PubMed ID: 24012659
[TBL] [Abstract][Full Text] [Related]
18. TW-37, a small-molecule inhibitor of Bcl-2, inhibits cell growth and invasion in pancreatic cancer.
Wang Z; Song W; Aboukameel A; Mohammad M; Wang G; Banerjee S; Kong D; Wang S; Sarkar FH; Mohammad RM
Int J Cancer; 2008 Aug; 123(4):958-66. PubMed ID: 18528859
[TBL] [Abstract][Full Text] [Related]
19. Emodin suppresses hyaluronic acid-induced MMP-9 secretion and invasion of glioma cells.
Kim MS; Park MJ; Kim SJ; Lee CH; Yoo H; Shin SH; Song ES; Lee SH
Int J Oncol; 2005 Sep; 27(3):839-46. PubMed ID: 16077936
[TBL] [Abstract][Full Text] [Related]
20. The β-adrenoceptor antagonist, propranolol, induces human gastric cancer cell apoptosis and cell cycle arrest via inhibiting nuclear factor κB signaling.
Liao X; Che X; Zhao W; Zhang D; Bi T; Wang G
Oncol Rep; 2010 Dec; 24(6):1669-76. PubMed ID: 21042766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
